Journal of Heterocyclic Chemistry · 2020 · 14 citations · 40 references
PharmacyMedicinal ChemistryOncologyCancer PharmacologyDrug DiscoverySynthetic Medicinal ChemistryHeterocyclic ChemistryNatural Product Drug DiscoveryAntiproliferative AgentsAntiproliferative Drug ActionBioactive HeterocyclesCytotoxicity AssaysMedicinal Chemistry ApplicationsMedicinal HeterocyclesMulticomponent Reaction Chemistry
Abstract A series of 15 new hybrid perillyl‐4 H ‐pyrans compounds was straightforwardly synthesized by a strategy combining the multicomponent reaction and the copper‐catalyzed alkyne‐azide cycloaddition (CuAAC). The 2‐amino‐4 H ‐pyrans‐3‐carbonitrile containing the alkyne moiety was prepared via multicomponent reaction between 1,3‐dicarbonyl, a propargyloxy aromatic aldehyde and malononitrile or ethyl α‐cyanoacetate. The alkyne derivative was sequentially reacted with the perillyl azide component through the copper‐catalyzed [3+2] Huisgen cycloaddition reaction. The antiproliferative activity of hybrid compounds were evaluated against the human hepatoma HepG2/C3A cell line.
40